NCT01967862View on ClinicalTrials.gov

Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 17, 2018

Study Completion Date

September 17, 2018

Conditions
Recurrent Prostate Cancer
Interventions
PROCEDURE

computed tomography

Undergo CT

PROCEDURE

bone scan

Undergo bone scan

PROCEDURE

3-Tesla magnetic resonance imaging

Undergo axial MRI

PROCEDURE

diffusion-weighted magnetic resonance imaging

Undergo WB MRI

RADIATION

fluorine F 18 sodium fluoride

Undergo fluorine F 18 sodium fluoride PET/CT

PROCEDURE

computed tomography

Undergo fluorine F 18 sodium fluoride PET/CT

PROCEDURE

positron emission tomography

Undergo fluorine F 18 sodium fluoride PET/CT

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (2)

91010

City of Hope Medical Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT01967862 - Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter